WASHINGTON - A press conference was interrupted on Thursday when a drug executive fainted in the Oval Office while President Donald Trump was announcing a deal with drugmakers to lower the cost of obesity drugs.

What happened?

What we know:

On Thursday, Trump and drugmakers were speaking to the press regarding a deal with Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.

President Donald Trump looks on as Administrator for the Centers for Medicare & Medicaid Services Dr. Mehmet Oz and other help Gordon Findlay of Novo Nordisk, who passed out during an event where Trump made a statement on lowering drug prices in Expand

The Brief

During remarks by Eli Lilly CEO David Ricks in the Oval Office, Novo Nordisk exec

See Full Page